713 related articles for article (PubMed ID: 28611215)
1. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.
Fei T; Chen Y; Xiao T; Li W; Cato L; Zhang P; Cotter MB; Bowden M; Lis RT; Zhao SG; Wu Q; Feng FY; Loda M; He HH; Liu XS; Brown M
Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5207-E5215. PubMed ID: 28611215
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneous nuclear ribonucleoprotein (hnRNPL) in cancer.
Gu J; Chen Z; Chen X; Wang Z
Clin Chim Acta; 2020 Aug; 507():286-294. PubMed ID: 32376323
[TBL] [Abstract][Full Text] [Related]
3. RNA splicing and splicing regulator changes in prostate cancer pathology.
Munkley J; Livermore K; Rajan P; Elliott DJ
Hum Genet; 2017 Sep; 136(9):1143-1154. PubMed ID: 28382513
[TBL] [Abstract][Full Text] [Related]
4. Identification of Upregulated HNRNPs Associated with Poor Prognosis in Pancreatic Cancer.
Qiao L; Xie N; Bai Y; Li Y; Shi Y; Wang J; Liu N
Biomed Res Int; 2019; 2019():5134050. PubMed ID: 31355266
[TBL] [Abstract][Full Text] [Related]
5. Targeting RNA binding protein in prostate cancer.
Fei T
Mol Cell Oncol; 2017; 4(5):e1353855. PubMed ID: 29057311
[TBL] [Abstract][Full Text] [Related]
6. Cross-species global and subset gene expression profiling identifies genes involved in prostate cancer response to selenium.
Schlicht M; Matysiak B; Brodzeller T; Wen X; Liu H; Zhou G; Dhir R; Hessner MJ; Tonellato P; Suckow M; Pollard M; Datta MW
BMC Genomics; 2004 Aug; 5(1):58. PubMed ID: 15318950
[TBL] [Abstract][Full Text] [Related]
7. HnRNPL promotes Wilms tumor progression by regulating the p53 and Bcl2 pathways.
Luo X; Deng C; Liu F; Liu X; Lin T; He D; Wei G
Onco Targets Ther; 2019; 12():4269-4279. PubMed ID: 31213844
[No Abstract] [Full Text] [Related]
8. Chimeric transcript generated by cis-splicing of adjacent genes regulates prostate cancer cell proliferation.
Zhang Y; Gong M; Yuan H; Park HG; Frierson HF; Li H
Cancer Discov; 2012 Jul; 2(7):598-607. PubMed ID: 22719019
[TBL] [Abstract][Full Text] [Related]
9. HNRNPM controls circRNA biogenesis and splicing fidelity to sustain cancer cell fitness.
Ho JS; Di Tullio F; Schwarz M; Low D; Incarnato D; Gay F; Tabaglio T; Zhang J; Wollmann H; Chen L; An O; Chan THM; Hall Hickman A; Zheng S; Roudko V; Chen S; Karz A; Ahmed M; He HH; Greenbaum BD; Oliviero S; Serresi M; Gargiulo G; Mann KM; Hernando E; Mulholland D; Marazzi I; Wee DKB; Guccione E
Elife; 2021 Jun; 10():. PubMed ID: 34075878
[TBL] [Abstract][Full Text] [Related]
10. Pathway-guided analysis identifies Myc-dependent alternative pre-mRNA splicing in aggressive prostate cancers.
Phillips JW; Pan Y; Tsai BL; Xie Z; Demirdjian L; Xiao W; Yang HT; Zhang Y; Lin CH; Cheng D; Hu Q; Liu S; Black DL; Witte ON; Xing Y
Proc Natl Acad Sci U S A; 2020 Mar; 117(10):5269-5279. PubMed ID: 32086391
[TBL] [Abstract][Full Text] [Related]
11. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment.
Siebring-van Olst E; Blijlevens M; de Menezes RX; van der Meulen-Muileman IH; Smit EF; van Beusechem VW
Mol Oncol; 2017 May; 11(5):534-551. PubMed ID: 28296343
[TBL] [Abstract][Full Text] [Related]
12. Histone demethylase JMJD1A promotes alternative splicing of AR variant 7 (AR-V7) in prostate cancer cells.
Fan L; Zhang F; Xu S; Cui X; Hussain A; Fazli L; Gleave M; Dong X; Qi J
Proc Natl Acad Sci U S A; 2018 May; 115(20):E4584-E4593. PubMed ID: 29712835
[TBL] [Abstract][Full Text] [Related]
13. Androgen-regulated genes differentially modulated by the androgen receptor coactivator L-dopa decarboxylase in human prostate cancer cells.
Margiotti K; Wafa LA; Cheng H; Novelli G; Nelson CC; Rennie PS
Mol Cancer; 2007 Jun; 6():38. PubMed ID: 17553164
[TBL] [Abstract][Full Text] [Related]
14. The Long Noncoding RNA Cancer Susceptibility 9 and RNA Binding Protein Heterogeneous Nuclear Ribonucleoprotein L Form a Complex and Coregulate Genes Linked to AKT Signaling.
Klingenberg M; Groß M; Goyal A; Polycarpou-Schwarz M; Miersch T; Ernst AS; Leupold J; Patil N; Warnken U; Allgayer H; Longerich T; Schirmacher P; Boutros M; Diederichs S
Hepatology; 2018 Nov; 68(5):1817-1832. PubMed ID: 29790588
[TBL] [Abstract][Full Text] [Related]
15. hnRNPL expression dynamics in the embryo and placenta.
Mathew V; Mei A; Giwa H; Cheong A; Chander A; Zou A; Blanton RM; Kashpur O; Cui W; Slonim D; Mahmoud T; O'Tierney-Ginn P; Mager J; Draper I; Wallingford MC
Gene Expr Patterns; 2023 Jun; 48():119319. PubMed ID: 37148985
[TBL] [Abstract][Full Text] [Related]
16. Roles of Alternative RNA Splicing of the Bif-1 Gene by SRRM4 During the Development of Treatment-induced Neuroendocrine Prostate Cancer.
Gan Y; Li Y; Long Z; Lee AR; Xie N; Lovnicki JM; Tang Y; Chen X; Huang J; Dong X
EBioMedicine; 2018 May; 31():267-275. PubMed ID: 29759485
[TBL] [Abstract][Full Text] [Related]
17. FOXA1 knock-out via CRISPR/Cas9 altered Casp-9, Bax, CCND1, CDK4, and fibronectin expressions in LNCaP cells.
Albayrak G; Konac E; Ugras Dikmen A; Bilen CY
Exp Biol Med (Maywood); 2018 Aug; 243(12):990-994. PubMed ID: 30043639
[TBL] [Abstract][Full Text] [Related]
18. Profiling of differential expression of messenger RNA in normal, benign, and metastatic prostate cell lines.
Chakrabarti R; Robles LD; Gibson J; Muroski M
Cancer Genet Cytogenet; 2002 Dec; 139(2):115-25. PubMed ID: 12550771
[TBL] [Abstract][Full Text] [Related]
19. Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling.
Takayama KI
Biomolecules; 2019 Apr; 9(4):. PubMed ID: 30939845
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA FOXC2-AS1 facilitates the proliferation and progression of prostate cancer via targeting miR-1253/EZH2.
Chen Y; Gu M; Liu C; Wan X; Shi Q; Chen Q; Wang Z
Gene; 2019 Feb; 686():37-42. PubMed ID: 30389560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]